CANADIAN DAILY STOCK REPORT
BioSyent Inc. (TSXV:RX), Canada's 3rd largest Drug manufacturers company by market cap, has increased 1.3% but fell short of the 12-day Exponential Moving Average [EMA] of CAD7.32. Compared with the S&P/TSX 60 Index which fell 4.8 points (0.5%) in the day, the relative price increase was 1.8%. The volume was 0.5 times the average daily trading volume of 20,102 shares. The stock last traded at CAD7.20.
BIOSYENT BULLISH SIGNALS
RelSci News & Alerts gets you:
- 10 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
- Competitive business intelligence through daily data updates
- Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox